Oceanix is said to be rich in antioxidant enzymes, including superoxide dismutase (SOD), as well as essential fatty acids, vitamins, amino acids, and minerals.
Photo © iStockphoto.com/IPGGutenbergUKLtd
A new phytoplankton-based ingredient produced using patent-pending technology helps to promote peak physical performance and recovery. Lonza (Morristown, NJ) introduced the new ingredient, called Oceanix, at this week’s Natural Products Expo West trade show.
Oceanix is said to be rich in antioxidant enzymes, including superoxide dismutase (SOD), as well as essential fatty acids, vitamins, amino acids, and minerals. It is marketed for increasing the physiological response to oxidative stress, benefitting physical performance. Also, the natural, non-GMO ingredient offers consumers a clean-label, vegan ingredient.
“With its vegan origins, the Oceanix ingredient brings sports performance and wellness benefits together, appealing to a new set of consumers,” said Shane Durkee, vice president, platform innovation, R&D, for Lonza Consumer Health, in a press release. “More and more consumers are pushing their physical performance, both in terms of intensity and the duration of activity. These consumers want effective performance nutrition to support performance and recovery that’s also clean-label, non-GMO, high-quality, and clinically studied. Oceanix phytoplankton ingredient delivers on these consumer demands in a small, effective, once-a-day 25-mg dose.”
Lonza says the ingredient is suited for various sports nutrition applications, including dietary supplements, bars, drinks, and powders.
Visit the company at Natural Products Expo West booth # 4005.
PEA may support exercise performance in addition to its anti-inflammatory properties
June 26th 2024The branded palmitoylethanolamide (PEA) ingredient called Levagen+ significantly improved dynamic lower body power, and did not inhibit strength training adaptations unlike NSAIDs or other analgesics.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
Published: May 14th 2024 | Updated: May 15th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.